Vistakon has named Arthur Shedden, MD, MBA, Medical Safety Officer, Professional Development, responsible for pre- and post-marketing product assessment from a medical safety perspective. He will continue overseeing Medical Affairs for Pharmaceutical Products reporting to Colleen Riley, OD, MS, FAAO, Dipl CL, Vice President of Professional Development.

Dr. Shedden brings two decades of progressive experience in clinical research and pharmaceutical product development to the position. He joined Johnson and Johnson Vision Care in 2008 as Director, Medical Affairs, Vistakon Pharmaceuticals, overseeing Phase 4 clinical development for many of the company’s pharmaceutical products. Before joining Johnson & Johnson Vision Care, Dr. Shedden led teams in clinical development at Merck & Co., Inc. and in medical affairs at Pharmacia/Pfizer and Schering Plough. Read the full story at Contact Lens Spectrum